Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
SHTDY SINOPHARM GROUP CO
11.360
+0.180+1.61%
YOY
Do not show
Hide blank lines
(Q2)2022/06/30(FY)2021/12/31(Q4)2021/12/31(Q2)2021/06/30
Financial Ratios
Efficiency Ratios TTM
Cash Conversion Cycle(D)
7.34% 78.6677 18.38% 46.506 18.38% 46.506 2.69% 73.2888
Receivable Turnover(T)
-8.32% 2.7488 -5.14% 3.5001 -5.14% 3.5001 -0.80% 2.9983
Inventory Turnover(T)
-3.60% 9.058 4.28% 9.6769 4.28% 9.6769 5.61% 9.3961
Fixed Assets Turnover(T)
3.09% 27.8409 9.80% 30.0635 9.80% 30.0635 12.43% 27.0063
Total Asset Rate(T)
-3.20% 1.4931 2.59% 1.6115 2.59% 1.6115 4.81% 1.5423
ROIC
-3.15% 6.889% -2.27% 8.008% -2.27% 8.008% 9.60% 7.113%
ROE
-9.37% 13.004% -5.25% 13.123% -5.25% 13.123% 11.72% 14.349%
ROA
-8.99% 2.203% -2.99% 2.400% -2.99% 2.400% 13.84% 2.420%
FCF to Sales
-95.06% 0.086% -31.87% 1.354% -31.87% 1.354% 255.63% 1.736%
FCF to Net Income
-94.74% 5.815% -27.95% 90.898% -27.95% 90.898% 227.35% 110.632%
Efficiency Ratios
ROE 5 Year Average
-- -- -2.54% 14.303% -- -- -- --
ROA 5 Year Average
-- -- -5.16% 2.690% -- -- -- --
Average 5 Years ROIC
-- -- -2.84% 8.899% -- -- -- --
Profitability Ratios TTM
Gross Margin
-2.80% 8.459% -4.31% 8.454% -4.31% 8.454% -0.25% 8.703%
Operating Margin
-2.31% 4.145% -5.07% 4.115% -5.07% 4.115% 0.81% 4.243%
Net Margin
-5.99% 1.475% -5.44% 1.489% -5.44% 1.489% 8.62% 1.569%
EBITDA Margin
-3.71% 0.047% -4.42% 0.0474% -4.42% 0.0474% 2.32% 0.0489%
R & D Expense Ratio
-- 0.000% -- 0.000% -- 0.000% -- 0.000%
Sales Expense Ratio
-5.18% 2.930% -4.52% 2.960% -4.52% 2.960% 1.64% 3.090%
Administration Expense Rate
0.67% 1.500% -3.25% 1.490% -3.25% 1.490% -8.02% 1.490%
Financial Health Ratios
Long-Term Debt to Equity Ratio
-7.69% 21.730% -12.62% 18.855% -12.62% 18.855% 7.76% 23.540%
Total Assets to Common Equity
-1.76% 585.349% -1.86% 541.984% -1.86% 541.984% 1.09% 595.844%
Debt to Asset Ratio
-3.23% 145.323% -9.14% 110.475% -9.14% 110.475% -11.54% 150.180%
Current Ratio
1.18% 1.3064 1.11% 1.3266 1.11% 1.3266 1.70% 1.2911
Quick Ratio
0.93% 0.9796 2.41% 0.9986 2.41% 0.9986 3.37% 0.9705
GrowthRatios
Growth Ratios
Revenue CAGR(3Y)
-- -- -18.35% 14.785% -- -- -- --
Revenue CAGR(5Y)
-- -- 0.63% 15.083% -- -- -- --
Net Income CAGR(3Y)
-- -- -7.84% 9.958% -- -- -- --
Net Income CAGR(5Y)
-- -- -21.96% 10.794% -- -- -- --
Dividend CAGR(3Y)
-- -- 1.51% 6.319% -- -- -- --
Dividend CAGR(5Y)
-- -- -- 11.043% -- -- -- --
FCF 1 Year Growth
-- -- 49.64% -22.221% -- -- -- --
FCF CAGR(3Y)
-- -- -- 204.570% -- -- -- --
FCF CAGR(5Y)
-- -- 62.00% -2.230% -- -- -- --
Currency Unit
CNYCNYCNYCNY

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
Sinopharm Group Co., Ltd. is a distributor of pharmaceutical and healthcare products and a value added supply chain service provider in the People's Republic of China. It operates through the following business segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment provides distribution, logistics and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers and other suppliers. The Medical Devices segment consists of the distribution of medical devices in China. The Retail Pharmacy segment refers to the network of retail drug stores in major cities of China via direct operations and franchises. The Other Business segment comprises of the production and sale of pharmaceutical products, chemical reagents and laboratory supplies. The company was founded on January 8, 2003 and is headquartered in Shanghai, China.
CEO: --
Market: Pink Market
Listing Date: 09/23/2009
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist